Overview


According to FutureWise analysis, the market for Amniotic Membrane is expected to reach US$ 7,620.64 million by 2028 at a CAGR of 14.8%.

The amniotic membrane is a thin but tough membrane that lines the amniotic sac, which is the fluid-filled sac that protects the developing fetus by surrounding it during pregnancy. The amniotic membrane is composed of two layers: the inner layer, which is made up of a single layer of flattened cells, and the outer layer, which is made up of a thicker layer of connective tissue. The amniotic membrane has several important functions during fetal development. It serves as a barrier to prevent infections from reaching the developing fetus, and it also provides a cushion for the developing fetus, protecting it from physical trauma. Additionally, the amniotic membrane produces a variety of growth factors and other substances important for fetal development, including cytokines, chemokines, and extracellular matrix proteins.

In recent years, the amniotic membrane has been used in a variety of medical applications outside of pregnancy. For example, it has been used as a temporary wound covering for burns and other types of injuries, and it has been used in ophthalmic surgeries to promote healing and reduce scarring. The amniotic membrane has also been investigated for its potential as a source of stem cells, which could be used to treat a variety of medical conditions. Overall, the amniotic membrane is a versatile and important tissue with a wide range of potential medical applications.

FutureWise Market Research has published a report that provides an insightful analysis of Amniotic Membrane Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Amniotic Membrane Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • FzioMed, Inc.
  • Skye Biologics Inc
  • IOP Ophthalmics
  • Amniox Medical, Inc.
  • Amnio Technology, LLC
  • Applied Biologics LLC
  • Alliqua BioMedical, Inc.
  • Human Regenerative Technologies, LLC
  • Derma Sciences Inc.
  • MiMedx Group, Inc.
  • AlloCure
  • Bellicum Pharmaceuticals
  • Biogen Idec
  • BIOTIME
  • Bone Therapeutics
  • Cell Medica
  • CESCA THERAPEUTICS
  • Fibrocell Science

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Amniotic Membrane Market:

In January 2022, One of the top independent pharmaceutical firms in Europe, Laboratoires Thea SAS, signed a contract to buy seven branded ophthalmic products from Akorn Operating Company LLC, including AcellFX, which offers a protective environment or covering for ocular surface repair.

The amniotic membrane is a thin layer of tissue that surrounds the fetus during pregnancy. It is rich in growth factors, cytokines, and extracellular matrix proteins that have been shown to have regenerative properties. The use of amniotic membrane in various medical applications, including ophthalmology, wound healing, and orthopedics, has been increasing in recent years. The amniotic membrane market is primarily driven by the rising geriatric population, the increasing prevalence of chronic diseases, and the advancements in regenerative medicine. The demand for amniotic membrane in ophthalmology, wound healing, and orthopedics is expected to grow in the coming years, as it has been shown to promote tissue regeneration, reduce inflammation, and improve healing outcomes. Additionally, the increasing adoption of minimally invasive surgical procedures is expected to drive market growth, as amniotic membrane can be easily applied using minimally invasive techniques, such as injection or grafting.

However, the high cost of amniotic membrane products, lack of reimbursement policies, and ethical concerns regarding the collection of amniotic membrane are some of the major challenges faced by the market. Additionally, the COVID-19 pandemic has also impacted the market dynamics, with supply chain disruptions and reduced demand for elective procedures.

Despite these challenges, the amniotic membrane market is expected to grow throughout the forecast period, driven by the increasing investment in research and development activities to develop innovative products and the rising demand for regenerative medicine. Moreover, the increasing adoption of telemedicine and other digital health technologies is expected to improve the accessibility and delivery of amniotic membrane products to patients in remote areas. Thus, it is projected to drive the market growth in the coming years.

By Product Type

  • Cryopreservation of Amniotic Membrane
  • Lyophilized Amniotic Membrane
  • Others

By Application

  • Surgical Wounds
  • Ophthalmology
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers and Laboratory

By Region

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America dominates the market in 2022. The United States (US) and Canada's highly established healthcare infrastructure and the region's high local government healthcare spending make North America the largest regional market in terms of revenue. The presence of innovative products in this region may also have an impact on market expansion throughout the projection period. The market growth in the North American area is projected to be boosted by new product releases and ongoing innovation by industry participants. The United States dominates the target market. For instance, in May 2021, VIAGENEX, a family of amniotic allografts processed to retain the natural mechanical properties of amniotic tissue and a rich supply of extracellular matrix, cytokines, and growth factors, was introduced by VIVEX Biologics, Inc., is amongst the top regenerative medicine company specializing in the development of naturally sourced treatments. As a result, it is projected that the rigorous product development in North American nations would stimulate the expansion of the amniotic membrane market in the region. Additionally, based on application; the surgical wounds segment holds the highest market share of 36.3% in 2022.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Amniotic Membranes market by product type, by application, by end-user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate the competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Amniotic Membranes Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Amniotic Membranes Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Amniotic Membranes Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Amniotic Membranes Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Cryopreservation of Amniotic Membrane
        2. Lyophilized Amniotic Membrane
        3. Others

  • 8.   Amniotic Membranes Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Surgical Wounds
        2. Ophthalmology
        3. Others

  • 9.   Amniotic Membranes Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Specialized Clinics
        4. Research Centers and Laboratory

  • 10.   North America Amniotic Membranes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Amniotic Membranes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Amniotic Membranes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Amniotic Membranes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Fziomed, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Skye Biologics Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. IOP Ophthalmics
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Amniox Medical, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Amnio Technology, Llc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Applied Biologics Llc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Alliqua Biomedical, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Human Regenerative Technologies, Llc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Derma Sciences Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Mimedx Group, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Allocure
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Bellicum Pharmaceuticals
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Biogen Idec
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Biotime
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Bone Therapeutics
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Cell Medica
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
        17.Cesca Therapeutics
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.Fibrocell Science
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11